Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients

REFERENCES

• Ince PG, Eggett ChJ, Shaw PJ. The role of excitotoxicity in neurological disease. Rev Con-temp Pharmacother 1997; 8: 195–212.
   Google Scholar
• Keller JN, Mattson MP. Roles of lipid peroxida-tion in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 1998; 9: 105–16.
   PubMed Web of Science ®Google Scholar
• Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, Rothstein JD. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589–602.
   Google Scholar
• Hosler BA, Brown RH Jr. Superoxide dismutase and oxygen radical neurotoxicity. Curr Opin Neurol 1996; 9: 486–91.
   PubMed Web of Science ®Google Scholar
• Beal MF. Mechanisms of cell death in neuro-degenerative disorders. J Neurol 2000; 7 Suppl. 2: 1 — 4.
   Google Scholar
• Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the patho-genesis of human motor neuron disease. Neuron 1994; 13: 975–88.
   Google Scholar
• Figlewicz DA, Krizus A, Martinoli MG, Meininger V, Dib M, Rouleau GA, Julien JP. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757 — 61.
   Google Scholar
• Singh RJ, Karoui H, Gunther MR, Beckman JS, Mason RP, Kalyanaraman B. Reexamination of the mechanism of hydroxyl radical adducts formed from the reaction between familial amyotrophic lateral sclerosis-associated Cu, Zn superoxide dismutase mutants and H202. Proc Natl Acad Sci USA 1998; 95: 6675–80.
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97–112.
   PubMed Web of Science ®Google Scholar
• Liu D. The roles of free radicals in amyotrophic lateral sclerosis. J Mol Neurosci 1996; 7: 159–67.
   PubMed Web of Science ®Google Scholar
• Floyd RA, Carney JM. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxida-tive stress. Ann Neurol 1992; 32: 22–7.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Role of free radicals in the neuro-degenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001; 18: 685–716.
   PubMed Web of Science ®Google Scholar
• Lehucher-Michel MP, Lesgards JF, Delubac O, Stocker P, Durand P, Prost M. Oxidative stress and human disease. Current knowledge and per-spectives for prevention. Presse Med 2001; 30: 1076— 81.
   Google Scholar
• Brooks BR. El Escorial Word Federation of Neurology criteria for the diagnosis of amyo-trophic lateral sclerosis. J Neurol Sci 1994; Suppl. 124: 96–107.
   Google Scholar
• Riviere M, Meininger V, Zeisser P, Munsat T. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole. Arch Neurol 1998; 55: 526–8.
   PubMed Web of Science ®Google Scholar
• Liu D, Wen J, Liu J, Li L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J 1999; 13: 2318–28.
   PubMed Web of Science ®Google Scholar
• Liu R, Althaus JS, Ellerbrock BR, Becker DA, Gurney ME. Enhanced oxygen radical production in a transgenic mouse model of familial amyo-trophic lateral sclerosis. Ann Neurol 1998; 44: 763— 70.
   Google Scholar
• Bogdanov MB, Ramos LE, Xu Z, Beal MF. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J Neurochem 1998; 71: 1321–4.
   PubMed Web of Science ®Google Scholar
• Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 1998; 53: 66–77.
   Google Scholar
• Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH Jr, Beal MF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064–74.
   Google Scholar
• Fitzmaurice PS, Shaw IC, Kleiner HE, Miller RT, Monks TJ, Lau SS, Mitchell JD, Lynch PG. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 1996; 19: 797–8.
   PubMed Web of Science ®Google Scholar
• Bowling AC, Schulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61: 2322–5.
   PubMed Web of Science ®Google Scholar
• Oteiza PI, Uchitel OD, Carrasquedo F, Dubrovski AL, Roma JC, Fraga CG. Evaluation of antioxidants, protein, and lipid oxidation pro-ducts in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res 1997; 22: 535–9.
   PubMed Web of Science ®Google Scholar
• lhara Y, Mori A, Hayabara T, Kawai M, Namba R, Nobukuni K, Sato K, Kibata M. Superoxide dismutase and free radicals in sporadic amyo-trophic lateral sclerosis: relationship to clinical data. J Neurol Sci 1995; 134: 51 — 6.
   PubMed Web of Science ®Google Scholar
• Przedborski S, Donaldson DM, Murphy PL, Hirsch O, Lange D, Naini AB, McKenna-Yasek D, Brown RH Jr. Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neurodegeneration 1996; 5: 57 — 64.
   Google Scholar
• Bonnefont-Rousselot D, Lacomblez L, Jaudon M, Lepage S, Salachas F, Bensimon G, Bizard C, Doppler V, Delattre J, Meininger V. Blood oxidative stress in amyotrophic lateral sclerosis. J Neurol Sci 2000; 178: 57 — 62.
   Google Scholar
• Kasapoglu M, Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol 2001; 36: 209–20.
   PubMed Web of Science ®Google Scholar
• Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosella AM, Armstrong D. Correlates of markers of oxidative status in the general population. Am J Epidemiol 2001; 154: 348–56.
   PubMed Web of Science ®Google Scholar
• Wang XL, Rainwater DL, VandeBerg JF, Mitchell BD, Mahaney MC. Genetic contributions to plasma total antioxidant activity. Arterioscler Thromb Vasc Biol 2001; 21: 1190–5.
   PubMed Web of Science ®Google Scholar
• MacKinnon KL, Molnar Z, Lowe D, Watson ID, Shearer E. Measures of total free radical activity in critically ill patients. Clin Biochem 1999; 32: 263–8.
   Google Scholar
• Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK, Hall ED. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 147–57.
   Google Scholar